Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, KMC Speciality Hospitals (India)'s enterprise value is ₹23,344 Mil.
KMC Speciality Hospitals (India)'s EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹1,060 Mil. Therefore, KMC Speciality Hospitals (India)'s EV-to-EBITDA for today is 22.01.
The historical rank and industry rank for KMC Speciality Hospitals (India)'s EV-to-EBITDA or its related term are showing as below:
NSE:KMCSHIL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.91 Med: 20.65 Max: 40.07
Current: 22.01
During the past 13 years, the highest EV-to-EBITDA of KMC Speciality Hospitals (India) was 40.07. The lowest was 7.91. And the median was 20.65.
NSE:KMCSHIL's EV-to-EBITDA is ranked worse than 78.88% of 516
companies
in the Healthcare Providers & Services industry
Industry Median: 10.705
vs NSE:KMCSHIL: 22.01
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
KMC Speciality Hospitals (India)'s PE Ratio (TTM) for today is calculated as:
KMC Speciality Hospitals (India)'s share price for today is ₹141.65.
KMC Speciality Hospitals (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3.420.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, KMC Speciality Hospitals (India)'s EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMC Speciality Hospitals (India) EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KMC Speciality Hospitals (India)'s EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where KMC Speciality Hospitals (India)'s EV-to-EBITDA falls into.
KMC Speciality Hospitals (India)'s current Enterprise Value is ₹23,344 Mil.
KMC Speciality Hospitals (India)'s EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,060 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMC Speciality Hospitals (India) (NSE:KMCSHIL) has a EV-to-EBITDA of 22.01 as of Aug. 24, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on KMC Speciality Hospitals (India). This is near median its historical median of 20.65. Over the past decade, KMC Speciality Hospitals (India)'s EV-to-EBITDA has ranged from 7.91 to 40.07. According to the industry distribution chart, KMC Speciality Hospitals (India) ranks #407 out of 516 companies in the Healthcare Providers & Services industry, placing it in the top 78.9%.
Is KMC Speciality Hospitals (India)'s EV-to-EBITDA too high?
KMC Speciality Hospitals (India)'s current EV-to-EBITDA of 22.01 is near median its 10-year median of 20.65. Over the past 10 years, this metric has ranged from a low of 7.91 to a high of 40.07. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.71. KMC Speciality Hospitals (India)'s value of 22.01 is 105.6% above this industry median. Based on the distribution chart, KMC Speciality Hospitals (India) ranks #407 out of 516 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, KMC Speciality Hospitals (India) has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KMC Speciality Hospitals (India)'s EV-to-EBITDA compare to ?
According to the Healthcare Providers & Services industry distribution chart, KMC Speciality Hospitals (India) ranks #407 out of 516 companies for EV-to-EBITDA. This places KMC Speciality Hospitals (India) in the lower half of its industry. The industry median EV-to-EBITDA is 10.71. KMC Speciality Hospitals (India)'s value of 22.01 is 105.6% above this benchmark. Historically, KMC Speciality Hospitals (India)'s own EV-to-EBITDA has ranged from 7.91 to 40.07 over the past decade. While the company's 10-year median is 20.65 vs. the industry median of 10.71, KMC Speciality Hospitals (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.71, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMC Speciality Hospitals (India)'s current EV-to-EBITDA of 22.01 is 105.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on KMC Speciality Hospitals (India). For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMC Speciality Hospitals (India)'s current EV-to-EBITDA is 22.01, which is near median its own 10-year median of 20.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMC Speciality Hospitals (India) stock overvalued right now?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) (NSE:KMCSHIL) is currently considered Fairly Valued. The stock's GF Value™ is ₹130.07, compared to a current price of ₹141.65 — trading 8.9% above its estimated fair value. The current EV-to-EBITDA is 22.01, which is near median its 10-year median of 20.65 and 105.6% above the Healthcare Providers & Services industry median of 10.71. KMC Speciality Hospitals (India)'s overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For KMC Speciality Hospitals (India) (NSE:KMCSHIL), the current EV-to-EBITDA is 22.01 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMC Speciality Hospitals (India) (NSE:KMCSHIL) Overvalued in 2026?
Based on GuruFocus' analysis, KMC Speciality Hospitals (India) stock appears to be overvalued.
The current stock price of ₹141.65 is trading 8.9% above its estimated GF Value™ of ₹130.07.
GuruFocus considers KMC Speciality Hospitals (India) to be Fairly Valued.
Key valuation signals for NSE:KMCSHIL:
EV-to-EBITDA: 22.01 (near median its 10-year median of 20.65)
GF Value™: ₹130.07 vs. price of ₹141.65 (8.9% above fair value)
Industry Position: 105.6% above the Healthcare Providers & Services median (#407 of 516)
No single metric tells the full story. See the NSE:KMCSHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMC Speciality Hospitals (India) Ltd is a healthcare services and pharmacy company. It is engaged in the business of rendering medical and healthcare services. The company offers varieties of departments and care centers such as cardiac science, neurology and neuroscience, orthopedics, spine surgery, gastroenterology, liver diseases, and transplantation and vascular surgery. The company's sole operating segment is Medical and Healthcare Services. The company operates solely in India.
73GF Score
Get the complete analysis for NSE:KMCSHIL
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KMCSHIL has been successfully added to your 
